Roche SARS-CoV-2 Rapid Antigen Self Test Nasal Kits
The latest lateral flow device from Roche Diagnostics puts the power of rapid diagnosis in your hands, without the need for professional medical support. The test allows you to check for a presence of prevalent coronavirus strains (including all variants) within just 15-30 minutes, to a high degree of accuracy.
Each conventiently sized box contains five test kits in total, allowing users to test at home, while travelling or on the move with a simple to carry out and non-invasive nasal swab.
As this latest generation of devices are qualified for personal use, employers are able to provide them to staff to test outside the workplace to protect colleagues, clients and customers.
These tests are permitted for sale to members of the public and are open for anybody to purchase - ideally, offering valuable support people who are vulnerable to infection or in close contact with friends or family with specific healthcare needs. And, for people who want to monitor their health and protect their ability to work.
Lateral flow tests are an excellent way to detect potential asymptomatic cases of infection, which is very important given the speed of transmission of the Delta Variant across the UK at this time.
Please note: these are not able to be used for 'fit to fly' or 'testing for travel' as those travelling internationally require a test and certificate from an approved provider.
1x Box = 5x SARS-CoV-2 Rapid Antigen Test Kits
- 1 Box to 10 boxes = £39.90 each (£7.98 each)
- 11 boxes to 25 Boxes = £37.40 each (£7.48 each)
- 26 boxes to 50 boxes = £34.90 each (£6.98 each)
- 51+ Boxes = POA based on quantity, contact us for quotation
Contact our Biomedical Director, Joshua Boyd with your enquiry on 0333 015 2723
The latest lateral flow device from Roche Diagnostics puts the power of rapid diagnosis in your hands, without the need for professional medical support - allowing for testing at home or on the move
The quality of face masks healthcare workers wear makes a huge difference to their risk of coronavirus infection, Cambridge University Hospitals NHS Foundation Trust research has found.
The variant - B.1.617.2 - was detected in 151 local authorities in the week ending 15 May, an 18% weekly increase.